Table 4.
Univariate (n = 708) | Univariate (N = 397) | Multivariate | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | HR | 95% CI | P value | N | HR | 95% CI | P value | HR | 95% CI | P value | ||
Sex | Female | 63 | Ref | 39 | Ref | Ref | ||||||
Male | 645 | 1.363 | 1.01–1.839 | 0.0427 | 358 | 1.213 | 0.83–1.772 | 0.3189 | 1.322 | 0.898–1.945 | 0.1569 | |
Age | < 70 | 299 | Ref | 171 | Ref | Ref | ||||||
≧ 70 | 409 | 1.057 | 0.892–1.254 | 0.5217 | 226 | 0.941 | 0.745–1.19 | 0.6131 | 0.937 | 0.739–1.189 | 0.5919 | |
PS | 0 | 226 | Ref | 133 | Ref | |||||||
1 | 378 | 1.546 | 1.273–1.876 | < 0.0001 | 212 | 2.203 | 1.674–2.899 | < 0.0001 | 2.222 | 1.682–2.936 | < 0.0001 | |
≧ 2 | 104 | 3.331 | 2.548–4.355 | < 0.0001 | 52 | 4.142 | 2.822–6.08 | < 0.0001 | 4.006 | 2.627–6.108 | < 0.0001 | |
Smoking index | < 50 | 345 | Ref | |||||||||
≧ 50 | 352 | 1.039 | 0.876–1.233 | 0.6581 | ||||||||
Clinical diagnosis of IIPs | Not-IPF | 294 | Ref | |||||||||
IPF | 406 | 1.155 | 0.972–1.373 | 0.1022 | ||||||||
HRCT pattern | Inconsistent with the UIP pattern | 190 | Ref | |||||||||
UIP pattern | 243 | 0.884 | 0.712–1.098 | 0.265 | ||||||||
Possible UIP pattern | 275 | 1.095 | 0.888–1.349 | 0.3973 | ||||||||
History of AE | Presence | 11 | Ref | |||||||||
Absence | 689 | 1.45 | 0.775–2.714 | 0.2445 | ||||||||
Emphysema | Absence | 381 | Ref | |||||||||
Presence | 326 | 1.109 | 0.936–1.315 | 0.2317 | ||||||||
KL-6 | < 500 | 184 | Ref | 138 | Ref | Ref | ||||||
≧500, < 1000 | 221 | 1.305 | 1.04–1.638 | 0.0216 | 148 | 1.312 | 0.997–1.726 | 0.0522 | 1.161 | 0.871–1.547 | 0.308 | |
≧1000, < 2000 | 124 | 1.441 | 1.105–1.879 | 0.007 | 87 | 1.425 | 1.035–1.96 | 0.0298 | 1.323 | 0.952–1.841 | 0.0959 | |
≧2000 | 35 | 1.295 | 0.85–1.974 | 0.2292 | 24 | 1.367 | 0.804–2.323 | 0.2484 | 1.379 | 0.804–2.363 | 0.2428 | |
SP-D | < 110 | 203 | Ref | |||||||||
≧ 110, < 150 | 71 | 0.848 | 0.627–1.149 | 0.2882 | ||||||||
≧ 150, < 250 | 80 | 1.128 | 0.835–1.524 | 0.433 | ||||||||
≧ 250 | 52 | 0.862 | 0.604–1.231 | 0.4147 | ||||||||
%FVC | ≧ 80 | 296 | Ref | |||||||||
≧ 50, < 80 | 137 | 1.219 | 0.959–1.549 | 0.1053 | ||||||||
< 50 | 8 | 1.64 | 0.674–3.99 | 0.2759 | ||||||||
%DLco | ≧ 80 | 55 | Ref | |||||||||
< 80 | 183 | 1.172 | 0.826–1.664 | 0.3726 | ||||||||
Desaturation on exertion | Absence | 418 | Ref | 330 | Ref | Ref | ||||||
Presence | 80 | 1.57 | 1.177–2.096 | 0.0022 | 67 | 1.663 | 1.209–2.288 | 0.0018 | 0.858 | 0.654–1.125 | 0.2681 | |
Treatment for IIPs | No | 678 | Ref | |||||||||
Yes | 30 | 1.11 | 0.724–1.702 | 0.6309 | ||||||||
Histology of lung cancer | SCLC | 216 | Ref | 109 | Ref | Ref | ||||||
NSCLC | 492 | 1.01 | 0.839–1.217 | 0.9134 | 288 | 0.962 | 0.738–1.254 | 0.7729 | 1.094 | 0.767–1.561 | 0.6191 |
AE acute exacerbation, CI confidence interval, %Dlco predicted diffusing capacity of the lung for monoxide, %FVC predicted forced vital capacity, HRCT high-resolution computed tomography, Hx histology, IP interstitial pneumonia, KL-6 Krebs von den Lungen-6, NS not significant, NSCLC non-small cell lung cancer, OR odds ratio, PaO2 partial arterial pressure of oxygen, PS performance status, ref reference, SCLC small cell lung cancer, SP-D surfactant protein-D, UIP usual interstitial pneumonia.